EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Colchicine’s Role in Cardiovascular Disease Management

Leo F Buckley iD, Peter Libby iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-05 · 44 (5) · 1031-1041

DOI: 10.1161/atvbaha.124.319851 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-05. Verfasst von Leo F Buckley und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy (L.F.B.), Brigham and Women's Hospital, Boston, MA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Colchicine. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colchicine—an anti-inflammatory alkaloid—has assumed an important role in the management of cardiovascular inflammation ≈3500 years after its first medicinal use in ancient Egypt. Primarily used in high doses for the treatment of acute gout flares during the 20th century, research in the early 21st century demonstrated that low-dose colchicine effectively treats acute gout attacks, lowers the risk of recurrent pericarditis, and can add to secondary prevention of major adverse cardiovascular events. As the first Food and Drug Administration–approved targeted anti-inflammatory cardiovascular therapy, colchicine currently has a unique role in the management of atherosclerotic cardiovascular disease. The safe use of colchicine requires careful monitoring for drug-drug interactions, changes in kidney and liver function, and counseling regarding gastrointestinal upset. Future research should elucidate the mechanisms of anti-inflammatory effects of colchicine relevant to atherosclerosis, the potential role of colchicine in primary prevention, in other cardiometabolic conditions, colchicine’s safety in cardiovascular patients, and opportunities for individualizing colchicine therapy using clinical and molecular diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesColchicineHumansAnti-Inflammatory AgentsDrug InteractionsGout SuppressantsTreatment Outcome

Stichwörter der Autor:innen

cardiovascular systemcolchicinehumansinflammationkidneyliver

Substanzen

Anti-Inflammatory AgentsColchicineGout Suppressants

Autor:innen und Institutionen

  • Department of Pharmacy (L.F.B.), Brigham and Women's Hospital, Boston, MA.
  • Division of Cardiovascular Medicine (P.L.), Brigham and Women's Hospital, Boston, MA.

ORCID-Profile: Leo F Buckley, Peter Libby

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Buckley, L. F., & Libby, P. (2024). Colchicine’s Role in Cardiovascular Disease Management. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(5), 1031-1041. https://doi.org/10.1161/atvbaha.124.319851

Vancouver

Buckley LF, Libby P. Colchicine’s Role in Cardiovascular Disease Management. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(5):1031-1041. doi:10.1161/atvbaha.124.319851

BibTeX
@article{Buckley2024,
  author = {Buckley, Leo F and Libby, Peter},
  title = {Colchicine’s Role in Cardiovascular Disease Management},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  volume = {44},
  number = {5},
  pages = {1031--1041},
  doi = {10.1161/atvbaha.124.319851}
}
Kostenlos starten →